✦ LIBER ✦

522 Combination therapy with peginterferon alfa-2A (40KD) (PEGASYS®) plus ribavirin (COPEGUS®) in treatment-naive patients with chronic hepatitis C and genotype 1 infection: Individual estimated probability of sustained virological response (SVR)

✍ Scribed by O. Weiland; M.W. Fried; S.J. Hadziyannis; G.R. Foster; D. Messinger; K. Freivogel; M. Chaneac

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Treatment of patients with chronic hepat

✍ M. Swain; M.-Y. Lai; M.L. Shiffman; W.G. Cooksley; A. Abergel; M. Diago; M. Brun 📂 Article 📅 2003 🏛 Elsevier Science 🌐 English ⚖ 159 KB

619 Peginterferon α-2a (40 kDa) plus rib

📂 Article 📅 2005 🏛 Elsevier Science 🌐 English ⚖ 252 KB

505 The influence of cumulative exposure

✍ K.R. Reddy; M.W. Fried; M.L. Shiffman; S.J. Hadziyannis; H. Sette; T.R. Morgan; 📂 Article 📅 2004 🏛 Elsevier Science 🌐 English ⚖ 49 KB

503 Early prediction of sustained virolo

✍ P.J. Pockros; M. Diago; E. Gane; K.R. Reddy; D. Prati; M.L. Shiffman; P. Farci; 📂 Article 📅 2004 🏛 Elsevier Science 🌐 English ⚖ 65 KB

509 Sustained virological response after

✍ J.M. Sanchez-Tapias; M. Diago; P. Escartin; J. Enriquez; R. Moreno; M. Romero-Go 📂 Article 📅 2004 🏛 Elsevier Science 🌐 English ⚖ 63 KB

507 Early prediction of sustained virolo

✍ M. Rodriguez-Torres; F.J. Torriani; E. Lissen; N. Brau; M. Sulkowski; R. Sola; B 📂 Article 📅 2004 🏛 Elsevier Science 🌐 English ⚖ 49 KB